You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 26 No. 4, April 1972 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL ARTICLES
 This Article
 •References
 •Full text PDF
 •Correction
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (97)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Comparative Study of Acid Maltase Deficiency

Biochemical Differences Between Infantile, Childhood, and Adult Types

Corrado Angelini, MD; Andrew G. Engel, MD

Arch Neurol. 1972;26(4):344-349.


Abstract

Maltase ({alpha}-1,4-glucosidase) activity was determined at various pH values in tissues in infantile (heart, liver, skeletal muscle), childhood (heart, liver, skeletal muscle), and adult (liver, skeletal muscle, leukocytes) types of acid maltase deficiency (AMD) and in control tissues. In an infantile case of AMD, only traces of neutral maltase were present in heart, and this activity was significantly decreased in skeletal muscle and liver. In a childhood case of AMD, neutral maltase activity was decreased only in liver. No decreases of neutral maltase occurred in adult AMD tissues. An absolute decrease of leukocyte acid maltase was found in four and a relative decrease in one of five adults with AMD. A decrease in the pH 4.0/pH 6.5 ratio of leukocyte maltase activity may aid in the diagnosis of adult AMD.



Author Affiliations

Rochester, Minn

From the Mayo Clinic and Mayo Foundation, Rochester, Minn.


Footnotes

Accepted for publication Aug 4, 1971.

Reprint requests to Section of Publications, Mayo Clinic, 200 First St SW, Rochester, Minn 55901.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Progress in enzyme replacement therapy in glycogen storage disease type II
Angelini et al.
Therapeutic Advances in Neurological Disorders 2009;2:143-153.
ABSTRACT  

Recent advances and current clinical perspectives in the diagnosis and treatment of glycogenosis type II
Angelini
Neurology 2008;71:S1-S2.
FULL TEXT  

Lymphocyte {alpha}-Glucosidase in Late-Onset Glycogenosis Type II
Kuriyama et al.
Arch Neurol 1989;46:460-462.
ABSTRACT  

Childhood Acid Maltase Deficiency: A Clinical, Biochemical, and Morphologic Study of Three Patients
Matsuishi et al.
Arch Neurol 1984;41:47-52.
ABSTRACT  

Lipid Storage Myopathy in Infantile Pompe's Disease
Sarnat et al.
Arch Neurol 1982;39:180-183.
ABSTRACT  

Late-Onset Acid Maltase Deficiency: Detection of Patients and Heterozygotes by Urinary Enzyme Assay
Mehler and DiMauro
Arch Neurol 1976;33:692-695.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1972 American Medical Association. All Rights Reserved.